and 12/12-6). Wild type mice were infected with individual RSV isolates and treated with either an anti-TSLP neutralizing antibody or an isotype control. On day 4 post-infection, lungs were collected for evaluation of ILC2 numbers. TSLPR-deficient mice were infected to evaluate pathophysiology. The appropriate institutional review boards approved all experiments. RESULTS: Neutralization of TSLP at 6 hours or 36 hours post-infection decreased the total number of IL-13-producing ILC2 on day 4 postinfection with RSV strain 01/2-20 compared to isotype treated mice. Similarly, TSLP neutralization attenuated IL-13-producing ILC2 on day 4 post-infection in mice inoculated with the INSPIRE strains. Deficiency of TSLPR in mice led to attenuated weight loss, decreased IL-13 production, and reduced airway mucus accumulation without a negative impact on viral load. CONCLUSIONS: TSLP neutralization attenuated the IL-13-producing ILC2 response induced by multiple clinical isolates of RSV, including strains isolated as recently as 2012 that have known human pathogenic potential. These data suggest TSLP as an important therapeutic target during RSV infection.
Interrogation of the Effects of Rhinovirus on Th2
Promoting Pathways in Allergic Asthma Basophils and dendritic cells (DCs) are key players in promoting Th2driven inflammation in allergic asthma. We recently reported increased IgE responsiveness in circulating basophils of allergic asthmatics following RV exposure. Thus, we aimed to explore how RV infection impacts Th2associated pathways in basophils and DCs. METHODS: Allergic asthmatics (n59) were challenged intranasally with human rhinovirus 16. Flow cytometry was employed to capture global changes and extensively immunophenotype circulating basophils, myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) in fresh whole blood obtained pre-inoculation (day 0), and during acute (day 4) and convalescent (day 21) phases post-inoculation. The multi-dimensionsal data analysis software, viSNE, was used to generate cell clusters of similar phenotypes. RESULTS: During the acute phase, viSNE analysis revealed enhanced expression of activation markers on mDCs and pDCs including HLA-DR and CD86, in conjunction with unconventional markers on mDCs including CD63 and prostaglandin D2 receptor (CRTH2). Furthermore, expression of intracellular Syk increased both in mDCs and pDCs, with little change in FcεRIa. By contrast, basophils displayed increased expression of FcεRIa, Syk and CD63, and levels of FcεRIa and CD63 remained elevated at day 21. At baseline, asthmatics segregated into IL-4 hi (n56) and IL-4 lo (n53) subgroups based on the percentage of IL-4 + basophils, mDCs and pDCs. Paradoxically, IL-4 lo asthmatics developed more severe respiratory symptoms than the IL-4 hi group. CONCLUSIONS: Collectively these findings highlight complex cellular changes induced by RV infection in allergic asthmatics that do not fit a simple Th2 amplification model.
